Literature DB >> 2184993

Upper-limb and lower-limb exercise training in patients with chronic airflow obstruction.

F R Lake1, K Henderson, T Briffa, J Openshaw, A W Musk.   

Abstract

We designed a randomized controlled study to evaluate the benefit of upper-limb exercise training, alone and in combination with walking training, in patients with severe CAO. In an outpatient department supervised by a physiotherapist, we evaluated 28 patients with severe stable CAO (FEV1, 32 percent of predicted). Patients were randomly allocated to either a control (eight), upper-limb (six), lower-limb (seven), or combined (seven) exercise group. The upper-limb group trained with a circuit of upper-limb exercises, the lower-limb group by walking, and the combined group with both. Exercise was for one hour three times per week for eight weeks. Assessment before and after training included pulmonary function, mouth pressures, respiratory muscle endurance, maximal bicycle exercise test, maximal and submaximal arm ergometer, six-minute walking distance, and a scale of well-being (Bandura scale). Twenty-six patients completed the program. There was a significant improvement (Wilcoxon rank sum test) in the following: six-minute walking distance in the lower-limb (p less than 0.005) and combined (p less than 0.003) groups; arm ergometer in the upper-limb (p less than 0.005) and combined (p less than 0.04) groups; and the scale of well-being in the combined (p less than 0.005) group. There was no significant change in any other parameter measured. We conclude that exercise training improves exercise performance in severe CAO, that the training is specific for the muscle group trained, and that upper-limb exercises should be included in training programs for these patients.

Entities:  

Mesh:

Year:  1990        PMID: 2184993     DOI: 10.1378/chest.97.5.1077

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Effect of upper extremity exercise in people with COPD.

Authors:  Ganesan Kathiresan; Senthil Kumar Jeyaraman; Jayachandran Jaganathan
Journal:  J Thorac Dis       Date:  2010-12       Impact factor: 2.895

2.  Rehabilitation for people with chronic lung disease.

Authors:  M D Morgan; F H Quirk; S J Singh
Journal:  Qual Health Care       Date:  1995-12

Review 3.  How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction.

Authors:  M A Puhan; H J Schünemann; M Frey; M Scharplatz; L M Bachmann
Journal:  Thorax       Date:  2005-05       Impact factor: 9.139

Review 4.  Exercise and cystic fibrosis.

Authors:  A K Webb; M E Dodd; J Moorcroft
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

Review 5.  Home versus center based physical activity programs in older adults.

Authors:  N L Ashworth; K E Chad; E L Harrison; B A Reeder; S C Marshall
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

6.  Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials.

Authors:  Ghassan F Salman; Michael C Mosier; Brent W Beasley; David R Calkins
Journal:  J Gen Intern Med       Date:  2003-03       Impact factor: 5.128

7.  Effect of upper limb, lower limb and combined training on health-related quality of life in COPD.

Authors:  Vaishali Rao; V Prem
Journal:  Lung India       Date:  2010-01

8.  Does pulmonary rehabilitation work in clinical practice? A review on selection and dropout in randomized controlled trials on pulmonary rehabilitation.

Authors:  Bodil Bjoernshave; Jens Korsgaard; Claus Vinther Nielsen
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

Review 9.  Pulmonary rehabilitation for patients with chronic pulmonary disease (COPD): an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01

Review 10.  Exercise in patients with chronic obstructive pulmonary disease.

Authors:  M J Belman
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.